Skip to content

FarmaST

Active
Private limited companyfounded 20233 yrs activeMolenweg 117, 3520 Zonhoven, BelgiumKBO/BCE: BE 0799.144.002

The computed 12-month bankruptcy probability of FarmaST is 1.7% (moderate). The 2025 annual accounts show equity of €97k and a net result of €34k. Equity is growing by ~55.8% per year across the filed fiscal years. Its solvency ranks better than 94% of 17964 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
93 / 100
Excellent= vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Stability94
Bankruptcy probability, 12 months
1.7% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €9k at 30 days acceptable
Liquidity ample (current ratio 12.12 against 10.36 in 2024), and 9.9% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 3 years 0 10 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
90.1%
Return on assets
32%
Age of the figures
8 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-06-2026, 58 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
58 d early
2024
58 d early
2023
6 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
13-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€97k▲ 55.0%
2024 · €62k
2023: €27k 2024: €62k
2023 → 2025
Total assets
€107k▲ 51.1%
2024 · €71k
2023: €32k 2024: €71k
2023 → 2025
Net result
€34k▼ 2.9%
2024 · €35k
2023: €23k 2024: €35k
2023 → 2025
Working capital
€97k▲ 51.9%
2024 · €64k
2023: €28k 2024: €64k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line202320242025Trend
Equity€27k-€62k▲ 131%€97k▲ 55.0%
Operating result€29k-€45k▲ 52.5%€43k▼ 3.1%
Net result€23k-€35k▲ 53.3%€34k▼ 2.9%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€20k€40kOperating result 2023: €29k€29kNet result 2023: €23k€23kOperating result 2024: €45k€45kNet result 2024: €35k€35kOperating result 2025: €43k€43kNet result 2025: €34k€34k202320242025
The operating result falls in 2025; 2025 is 3% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €107k
Fixed assets €1k
Current assets €106k
Equity and liabilities €107k
Equity €97k▲ 55.0%
Debt €11k▲ 23.3%
The debt ratio falls from 12.1% to 9.9%: equity grows faster than debt.
Key figures and ratios
2025 value · change against 2024
EBITDA
€44k
Cash flow
€35k
Solvency
90.1%
2024 · 87.9%
Current ratio
12.12
2024 · 10.36
Quick ratio
12.12
2024 · 10.36
Debt / equity
0.11
2024 · 0.14
ROE
35.5%
2024 · 56.6%
ROA
32.0%
2024 · 49.8%
Interest coverage
1086.41
Debt
€11k
2024 · €9k
Debt ≤ 1 year
€9k
2024 · €7k
Income taxes
€9k
2024 · €10k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€71k€107k
Fixed assets21/28-€1k
Tangible fixed assets22/27-€1k
Furniture and vehicles24-€1k
Current assets29/58€71k€106k
Amounts receivable within one year40/41€12k€13k
Trade receivables40€10k€12k
Other amounts receivable41€2k€1k
Cash at bank and in hand54/58€58k€93k
Deferred charges and accrued income490/1€48€62
Equity and liabilities
Total equity and liabilities10/49€71k€107k
Equity10/15€62k€97k
Contributions10/11€4k€4k=
Reserves13€58k€93k
Distributable reserves133€58k€93k
Amounts payable17/49€9k€11k
Amounts payable within one year42/48€7k€9k
Trade debts44€2k€1k
Suppliers440/4€2k€1k
Taxes, remuneration and social security45€5k€7k
Taxes450/3€3k€5k
Remuneration and social security454/9€2k€2k=
Other amounts payable47/48€98€84
Accrued charges and deferred income492/3€2k€2k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€520
Other operating charges640/8€62€62
Gross operating margin9900€45k€44k
Operating profit (loss)9901€45k€43k
Financial income75/76B€98€227
Recurring financial income75€98€227
Financial charges65/66B€39€40
Recurring financial charges65€39€40
Profit (loss) for the period before taxes9903€45k€44k
Income taxes67/77€10k€9k
Profit (loss) for the period9904€35k€34k
Profit (loss) for the period to be appropriated9905€35k€34k
Appropriation of the result
Profit (loss) to be appropriated9906€35k€34k
Transfer to equity691/2€35k€34k
To other reserves6921€35k€34k

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
03-06
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
03-06
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Highest result since 2023net €35k ▲53.3%
Operating result €45k, net result €35k, both a record.
06-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 6 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zonhoven · 1 establishment unit since 2023
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Molenweg 1173520 Zonhoven
Ground area
863 m²
Building footprint
212 m²
Volume, LiDAR
1,713 m³
Parcel 71442D0124/00B030, Flanders · tallest building 13.5 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
FarmaST
Molenweg 117, 3520 ZonhovenManufacture of chemicals and chemical products
since 20232.342.264.839
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
71442D0124/00B030 Flanders 863 m² 1 · 211 m² 13.5 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 5,208 companies in sector 47730 we hold annual accounts for 3,850. 3,391 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded03-03-2023
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
47120Other non-specialised retail sale
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
47750Retail sale of cosmetics and toilet articles
47910Retail trade
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers

Data from official sources, last processed on 13-09-2026. Scores and ratios are computed by Checked and are not a credit decision.